US Patent Issued to The Rockefeller University, California Institute of Technology on March 4 for "HIV vaccine immunogens" (New York, California Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,698, issued on March 4, was assigned to The Rockefeller University (New York) and California Institute of Technology (Pasadena, Calif.).

"HIV vaccine immunogens" was invented by Michel Nussenzweig (New York), Pamela J. Bjorkman (Altadena, Calif.), Amelia Escolano (New York) and Harry Gristick (Pasadena, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infectio...